Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Sodium Carbonate | HCID 10340 | — |
| Reactant | (-)-Physostigmine salicylate | HCID 657348 | — |
| Solvent | Water | HCID 962 | — |
| Solvent | Dichloromethane | HCID 6344 | — |
| Product | Physostigmine | HCID 5983 | 100.8% |
Reaction Steps
To a heterogeneous mixture of physostigmine salicylate (450 g) in dichloromethane (1.35L) and water (1.35L) was added Na2CO3 (150 g) over 0.5-1.0 hour while maintaining 18°-20° C. During the addition the pH of the aqueous phase increases from 5.5 to 9.5. After stirring at 18°-20° C. for 0.5 hour the aqueous phase was separated and extracted with dichloromethane (2×112 mL). The combined dichloromethane phase was treated again with water (500 mL) and Na2CO3 (23 g) at 18°-20° C. and stiffed for 0.5 hour. The aqueous phase was separated, extracted with dichloromethane (2×112 mL) and the combined dichloromethane phases were washed with water (450 mL), dried over K2CO3 (20 g) and concentrated under reduce pressure below 30° C. to give 302 g of crystalline physostigmine free base (100.8% of theory, 99.0% HPLC purity).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US05498726 |
|---|
| Source dataset | uspto-grants-1996_03 |
|---|
| ORD ID | ord-ca543a15df40455a9a36932f289305de |
|---|
| Source note | uspto-grants-1996_03 |
|---|